首页> 外文期刊>The journal for nurse practitioners: JNP >Pharmaceutical Industry Sponsorship and the NP Prescriber: Policy and Practice Implications
【24h】

Pharmaceutical Industry Sponsorship and the NP Prescriber: Policy and Practice Implications

机译:制药行业赞助和NP开处方者:政策和实践意义

获取原文
获取原文并翻译 | 示例
           

摘要

Pharmaceutical marketing has become ubiquitous in today's society. Acquisition of nonbiased, evidence-based information on drugs is essential for prescribers and is a key component of continuing professional development in the health professions. However, the process by which prescribers obtain information on drugs has come under increasing scrutiny over the past decade as institutional and legislative entities have questioned the propriety of health profession education that is funded by the pharmaceutical industry. This article provides important policy perspectives for this timely debate for nurse practitioners.
机译:在当今社会,药品营销已变得无处不在。获取无偏见的,循证医学的药物信息对于开药者至关重要,并且是卫生专业人员持续专业发展的关键组成部分。然而,在过去的十年中,由于机构和立法实体对由制药业资助的健康专业教育的适当性提出质疑,处方者获取药物信息的过程受到越来越多的审查。本文为护士从业人员及时辩论提供了重要的政策见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号